Related Experiment Video
Updated: Mar 22, 2026
06:10
Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
Published on: August 23, 2022
2.6K
Cholestasis beyond the Neonatal and Infancy Periods
Racha Khalaf1, Claudia Phen1, Sara Karjoo2
1Department of Medical Education, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Pediatric Gastroenterology, Hepatology & Nutrition
|April 12, 2016
Summary
Cholestasis, a bile excretion disorder, requires prompt diagnosis and treatment. This review covers the pathophysiology, diagnosis, and management of pediatric cholestasis beyond infancy.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
Background:
- Cholestasis stems from impaired bile excretion, either via mechanical obstruction or defective canalicular excretion.
- Prompt diagnosis and treatment are crucial for cholestasis management.
- The differential diagnosis is broad, encompassing congenital and acquired causes, necessitating differentiation between intrahepatic and extrahepatic origins.
Purpose of the Study:
- To provide a comprehensive overview of cholestasis in pediatric patients beyond the neonatal and infancy periods.
- To discuss the pathophysiology, diagnostic strategies, and management approaches for cholestasis.
- To highlight the importance of nutritional and medical support in chronic cholestasis.
Main Methods:
- Literature review focusing on cholestasis in pediatric populations beyond infancy.
- Synthesis of information on cholestasis pathophysiology, diagnosis, and treatment.
- Emphasis on differentiating intrahepatic from extrahepatic causes.
Main Results:
- Cholestasis management is etiology-dependent, ranging from supportive care to curative interventions.
- Optimal nutritional and medical support are integral to managing chronic pediatric cholestasis.
- Accurate differentiation between intrahepatic and extrahepatic cholestasis is clinically imperative.
Conclusions:
- Effective management of pediatric cholestasis requires a thorough understanding of its diverse etiologies and origins.
- A multidisciplinary approach integrating diagnosis, treatment, and supportive care is essential.
- This review serves as a guide for clinicians managing cholestasis in older children.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
317
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
317
01:26Diseases of the Liver and Gallbladder
2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
01:29Chronic Pancreatitis II: Collaborative Care
467
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
467
01:17Chronic Bowel Disorders: Introduction
896
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
669
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
01:28Esophageal Varices-II: Clinical Features and Management
740
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
740